Page last updated: 2024-11-01

norfloxacin and HIV Coinfection

norfloxacin has been researched along with HIV Coinfection in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Akyala, AI1
Iwu, CJ1
Mwachari, CW1
Meier, AS1
Muyodi, J1
Gatei, W1
Waiyaki, P1
Cohen, CR1

Other Studies

2 other studies available for norfloxacin and HIV Coinfection

ArticleYear
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
    The Pan African medical journal, 2020, Volume: 37

    Topics: Anti-Retroviral Agents; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coinfecti

2020
Chronic diarrhoea in HIV-1-infected adults in Nairobi, Kenya: evaluation of risk factors and the WHO treatment algorithm.
    AIDS (London, England), 2003, Sep-26, Volume: 17, Issue:14

    Topics: Adult; Algorithms; Anti-Infective Agents; Chronic Disease; Cohort Studies; Diarrhea; Drug Therapy, C

2003